Human leukocyte antigen class II susceptibility conferring alleles among non-insulin dependent diabetes mellitus patients

Journal of the College of Physicians and Surgeons Pakistan

Volumn 21, Issue 1, 2011, Pages 26-29

  Tipu, Hamid Nawaz ^a   Ahmed, Tahir Aziz ^b   Bashir, Mohammad Mukarram ^b  

^a Peshawar Cantonment   (Pakistan)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (Pakistan)

Author keywords

Allele; Human leukocyte antigen; Non insulin dependent diabetes mellitus (NIDDM); Susceptibility; Type 2 diabetes mellitus

Indexed keywords

EDETATE DISODIUM; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN;

ADULT; AGAR GEL ELECTROPHORESIS; AGE DISTRIBUTION; ALLELE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DNA EXTRACTION; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; WORLD HEALTH ORGANIZATION;

ADULT; ALLELES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ELECTROPHORESIS, AGAR GEL; FEMALE; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED;

EID: 78651094131     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. World Health Organization. Diabetes action online: about diabetes [Internet]. [cited 2010 Mar 1]. Available from: http://www.who.int/diabetesactiononline/diabetes/basics/en/index.html
2. Diagnosis and classification of diabetes mellitus: position statement. Diabetes Care 2004; 27:5-10.
3. Das SK. Genetic epidemiology of adult onset type 2 diabetes in Asian Indian population: past, present and future. Int J Hum Genet 2006; 6:1-13.
4. Garmes HM. Value of genetic studies to identify type 2 diabetes susceptibility genes. Indian J Med Sci 2008; 62:257-8. Comment in: 259-66.
5. Rao PV, Ushabala P, Ahuja MM. Genetics of diabetes mellitus: a review of Indian population studies. Int J Diab Dev Countries 1990; 10:41-7.
6. Nomura S, Shouzu A, Omoto S, Matsuzaki T, Yamaoka M, Abe M, et al. Genetic analysis of HLA, NA and HPA typing in type 2 diabetes and ASO. Int J Immunogenet 2006; 33:117-22.
7. Miklossy J, Martins R, Darbinian N, Khalili K, McGeer PL. Type 2 diabetes: local inflammation and direct effect of bacterial toxic components. Open Pathology J 2008; 2:86-95.
8. Motala AA, Busson M, Al-Harbi EM, Khuzam MAA, Al-Omari EMD, Arekat MR, et al. Susceptible and protective human leucocyte antigen class II alleles and haplotypes in Bahraini type 2 (non-insulin dependent) diabetes mellitus patients. Clin Diagn Lab Immunol 2005; 12:213-7.
9. Almawi WY, Wakim-Ghorayeb SF, Arekat MR, Najm P, Keleshian SH, Al-Sayed N, et al. Association of selective HLA class II susceptibility conferring and protective haplotypes with type 2 diabetes in patients from Behrain and Lebanon. Clin Vaccin Immunol 2006; 13:1296-8. Epub 2006 Sep 20.
10. Tuomi T. Type 1 and type 2 diabetes: what do they have in common. Diabetes 2005; 54:40-5.
11. Kahn CR, Vicent D, Doria A. Genetics of non-insulin dependent (type II) diabetes mellitus. Ann Rev Med 1996; 47:509-31.
12. Yang HY, Xue L, Xu M, Ren CF, Yuan HY, Tai WL, et al. [Study on the association between HLA DRB1 alleles and type 2 diabetes in Yi nationality of Yunnan]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2007; 24:101-3. Chinese.
13. Haruhiko O, Hiroshi O, Hideichi M. Type 2 diabetes susceptibility genes. Shikoku J Clin Chem 2002; 19:3-11.
14. World Health Organization. Diabetes action online: about diabetes-values for diagnosis of diabetes mellitus and other categories of hyperglcaeamia [Internet]. [cited 2010 Apr 18]. Available from: http://www.who.int/diabetesactiononline/diabetes/basics/en/index4.html
15. Diagnosis and classification of diabetes mellitus: American Diabetes Association position statement. Diabetes Care 2006; 29:43-8.
16. Qaigen. Gentra: automated DNA purification for archival-quality DNA [Internet]. [cited 2010 Apr 18]. Available from: http://www.qiagen.com/products/dna.aspx?r=2914
17. Tipu HN, Ahmed TA, Ahmed S. Validity of human leukocyte antigen class II typing in-house assay in comparison with commercial kit. Pak J Pathol 2008; 19:121-5.
18. Shankarkumar U. The human leukocyte antigen (HLA) system. Int J Hum Genet 2004; 4:91-103.
19. Trabace S. HLA and disease association. J Headache Pain 2000; 1:109-13.
20. Al-Hussein KA, Rama NR, Ahmad M, Rosemuller E, Tilanus MG. HLA-DPB1*0401 is associated with dominant protection against type 1 diabetes in the general Saudi population and in subjects with a high-Risk DR/DQ haplotype. Eur J Immunogenet 2003; 30:115-9.
21. Mahler RJ, Adler ML. Type 2 diabetes mellitus: update on diagnosis, pathophysiology and treatment. J Clin Endocrinol Metabol 1999; 84:1165-71.
22. Ashraf SM, Ziauddin F, Jahangeer U. Metabolic syndrome in type 2 diabetes mellitus. Pak J Med Sci 2006; 22:295-9.
23. Basit A, Hydrie MZ, Hakeem R, Ahmedani MY, Waseem M. Glycemic control, hypertension and chronic complications in type 2 diabetic subjects attending a tertiary care centre. J Ayub Med Coll Abbottabad 2005; 17:63-8.
24. Saifullah, Mujtaba G. Diabetic's skin: a storehouse of infections. J Pak Assoc Derma 2009; 19:34-7.
25. Anwar M, Iqbal M, Ahmed TA, Bashir M, Ayyub M, Naeem M. HLA frequencies in Pakistani population in comparison with Caucasian, oriental and Negroid population. Pak J Pathol 2006; 17:29-33.